Essameldin Abdelaziz Mohamed Ahmed Nada

Professor - Prof. of Dermatology,Venereology and Andrology

Faculty of medicine

Address: 8 Abou Bakr ElSedik Dokki Giza


1993 | Keywords HLA Typing, Androgenetic alopecia,
Determination of HLA Typing in Androgenetic Alopecia. Egypt.
Thirty cases of healthy classic androgenetic alopecia (male to female ratio was 1 :1 were chosen for this study, and subjected to HLA detection of class I antigen (HLA-A, 8 and C) and class II antigens (DR1, DR2, DR3, DR4, DR7, DRW52, DRW53 and DQW1) and compared with thirty five controls of a previous study of normal Egyptians. In the ... Read more

Hormones Profile in Androgenetic Alopecia.
Thirty cases with androgenetic alopecia and ten healthy controls (male to female ratio was 1:1) were subjected to the measurement of serum hormonal levels (total testosterone, free testosterone, dehydro- epiandrosterone sulphate, estradiol, progesterone and prolactin). All hormones were analysed by radioimmunoassay technique. The evaluation of our hormonal findings revealed that there was a statistically significant increase in serum estradiol levels ... Read more

Efficacy of medical treatment in varicocele patients presenting with oligoasthenoteratozoospermia
BACKGROUND: Varicocele is the most common cause of male infertility. It affects spermatogenesis by multiple theories; the most recent is by increasing the levels of reactive oxygen species. Medical treatment in the form of tamoxifen, anti-oxidant (Zinc) and MPFF (Micronised purified flavonoid fractions), may improve spermatogenesis and semen parameters in patients with varicocele. AIM: show the efficacy of medical treatment ... Read more

: The use of Escitalopram in treatment of patients with premature ejaculation: A randomized, double-blind, placebo-controlled study.
OBJECTIVE: To investigate the efficacy of escitalopram in treatment of premature ejaculation (PE). DESIGN: A randomized, double-blind placebo-controlled study. METHODS: Patients with PE (n=30) were randomly divided into two treatment groups: a group receiving Escitalopram I 0 mg daily for I month (n=l 5); and a group receiving placebo for 1 month (n= 15). A modified version of the Chinese ... Read more